The company plans to target healthcare or healthcare-related industries, particularly North American or European life sciences and medical technology companies.
The Zhitong Finance App learned that Perceptive Capital Solutions, a special purpose acquisition company (SPAC) supported by Perceptive Advisors, submitted an IPO application to the US Securities and Exchange Commission (SEC) on Tuesday and plans to raise up to 75 million US dollars. The company plans to target healthcare or healthcare-related industries, particularly North American or European life sciences and medical technology companies.
Perceptive Capital Solutions plans to issue 7.5 million shares at a price of $10 per share and raise $75 million. This offering does not include warrants or other rights. According to the proposed deal size, Perceptive Capital Solutions' market capitalization will reach $97 million.
The company is headed by Chairman Joseph Edelman (founder, CEO, and portfolio manager of life sciences-focused investment firm Perceptive Advisors) and CEO and Director Adam Stone (Chief Information Officer of Perceptive Advisors).
Perceptive Advisors has supported several SPACs, most recently ARYA Sciences Acquisition IV (merger agreement with cryo-ablation company Adagio Medical) and ARYA Sciences Acquisition V (liquidated in 2023).
Perceptive Capital Solutions was founded in 2024 and plans to be listed on NASDAQ under the code PCSC. The company secretly submitted the application on April 16, 2024. Jefferies was the sole bookkeeper for this transaction.